Caribou Biosciences Investor
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Investors
Technology:
Biotech, CAR-T, Cell-based gene therapy, Cell_Therapies
Industry:
AgTech, Public
Headquarters:
Berkeley, California, United States
Founded Date:
2011-01-01
Employees Number:
101-250
Funding Status:
IPO
Investor Type:
Late Stage Venture
Investment Stage:
N/A
Number Of Exits:
1
Investors Number:
31
Total Funding:
167549904
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-03-03
Last Funding Type:
Series C
Register and Claim Ownership